Pathophysiology of diabetic dyslipidaemia: where are we?

Glycation of Apolipoprotein C1 Impairs Its CETP Inhibitory Property: Pathophysiological Relevance in Patients With Type 1 and Type 2 Diabetes

(2014) Benjamin Bouillet et al.   DIABETES CARE

Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study

(2014) Bruno Vergès et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases

(2013) Janet D. Sparks et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol

(2013) F. Shojaee-Moradie et al.   DIABETES

Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity

(2013) J. Hyysalo et al.   DIABETES

The Effects of Type 2 Diabetes on Lipoprotein Composition and Arterial Stiffness in Male Youth

(2013) Scott M. Gordon et al.   DIABETES

Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men

(2013) J. Wang et al.   JOURNAL OF INTERNAL MEDICINE

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

(2013) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia

(2012) Janet D. Sparks et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Absence of Acute Inhibitory Effect of Insulin on Chylomicron Production in Type 2 Diabetes

(2012) Juan-Patricio Nogueira et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Retinol-Binding Protein 4 Is an Independent Factor Associated With Triglycerides and a Determinant of Very Low-Density Lipoprotein–Apolipoprotein B100 Catabolism in Type 2 Diabetes Mellitus

(2012) Bruno Vergès et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes

(2012) Marie-Claude Brindisi et al.   ATHEROSCLEROSIS

Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity

(2012) Martin Adiels et al.   ATHEROSCLEROSIS

Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis

(2012) Marcello Arca et al.   Current Vascular Pharmacology

GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion

(2012) J. Doucet et al.   DIABETES & METABOLISM

Predictors of Mortality Over 8 Years in Type 2 Diabetic Patients: Translating Research Into Action for Diabetes (TRIAD)

(2012) L. N. McEwen et al.   DIABETES CARE

Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men

(2012) E. Søndergaard et al.   DIABETOLOGIA

Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes

(2012) M. Ståhlman et al.   DIABETOLOGIA

Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease

(2012) Xavier Pillois et al.   JOURNAL OF LIPID RESEARCH

Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects

(2011) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism

(2011) Ratna Karuna et al.   ATHEROSCLEROSIS

Insulin Silences Apolipoprotein B mRNA Translation by Inducing Intracellular Traffic into Cytoplasmic RNA Granules

(2011) Navaz Karimian Pour et al.   BIOCHEMISTRY

Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes: A report from the Swedish National Diabetes Register

(2011) B. Eliasson et al.   DIABETES CARE

Small Dense LDL Enhances THP-1 Macrophage Foam Cell Formation

(2011) Mariko Tani et al.   Journal of Atherosclerosis and Thrombosis

Endogenous Chronic Hyperinsulinemia Does Not Increase the Production Rate of VLDL Apolipoprotein B: Proof from a Kinetic Study in Patients with Insulinoma

(2011) Laurence Duvillard et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI

(2011) Ailing Ji et al.   JOURNAL OF LIPID RESEARCH

Type 2 Diabetes Is Associated with Reduced ATP-Binding Cassette Transporter A1 Gene Expression, Protein and Function

(2011) Dipesh C. Patel et al.   PLoS One

Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes

(2010) Bruno Vergès   ATHEROSCLEROSIS

Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin

(2010) N. Rabbani et al.   DIABETES

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study

(2010) M. L. Norgaard et al.   DIABETOLOGIA

Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy

(2009) Sajoscha A. Sorrentino et al.   CIRCULATION

Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes

(2009) Esther M.M. Ooi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH

(2009) Francisco Caballero et al.   JOURNAL OF HEPATOLOGY

Apolipoprotein M predicts pre-β-HDL formation: studies in type 2 diabetic and nondiabetic subjects

(2009) P. Plomgaard et al.   JOURNAL OF INTERNAL MEDICINE

Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia

(2009) Giovanni Annuzzi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance

(2008) Alexander Laatsch et al.   ATHEROSCLEROSIS

Intestinally derived lipids: Metabolic regulation and consequences—An overview

(2008) Katherine Cianflone et al.   ATHEROSCLEROSIS SUPPLEMENTS

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages

(2008) Kazumi Tsubakio-Yamamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans

(2008) Hélène Duez et al.   CIRCULATION

Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus

(2008) Jeremy P. Mauldin et al.   CIRCULATION

Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention

(2008) Weidong Zhu et al.   CLINICAL SCIENCE

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism

(2008) L. Qiao et al.   DIABETES

Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database

(2008) H. E. Mulnier et al.   DIABETOLOGIA

Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitus

(2008) Michael Stolinski et al.   METABOLISM-CLINICAL AND EXPERIMENTAL